Sign Up
OverviewAPI
The COVID subvariant JN.1 accounts for about 62% of cases in the U.S., making it the most widely circulated variant globally. It is also the dominant variant in Europe and is rising sharply in Asia. While there is no evidence of more severe disease, current vaccines are expected to increase protection against it.

Ask a question